Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02099370 · ClinicalTrials.gov registry record
Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients
A clinical trial, sponsored by University of South Florida.
- Completed
- Registry status
- 34
- Enrollment target
NCT02099370: Completed study, sponsored by University of South Florida.
NCT02099370 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02099370 has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
The investigators are measuring the adherence rates of an oral MS drug that is to be administered twice-daily. The investigators would like to observe any patterns that might indicate factors that greatly affect adherence.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-01 |
What the finished NCT02099370 record still lists
NCT02099370 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02099370 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02099370 about?
NCT02099370 is a clinical study titled "Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients". The investigators are measuring the adherence rates of an oral MS drug that is to be administered twice-daily. The investigators would like to observe any patterns that might indicate factors that greatly affect adherence.
What is the current status of trial NCT02099370?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2014-03. Estimated completion is 2016-01.
Who is sponsoring clinical trial NCT02099370?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia